These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14703276)

  • 1. Increased serum concentrations of tumor necrosis factor-alpha are associated with disease progression and malnutrition in hepatocellular carcinoma.
    Wang YY; Lo GH; Lai KH; Cheng JS; Lin CK; Hsu PI
    J Chin Med Assoc; 2003 Oct; 66(10):593-8. PubMed ID: 14703276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis.
    Lin SY; Wang YY; Sheu WH
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):805-11. PubMed ID: 12460331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection.
    Ataseven H; Bahcecioglu IH; Kuzu N; Yalniz M; Celebi S; Erensoy A; Ustundag B
    Mediators Inflamm; 2006; 2006(4):78380. PubMed ID: 17047295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients.
    Okita M; Tomioka K; Ota Y; Sasagawa T; Osawa T; Sakai N; Kawaguchi M; Itoshima T
    Nutrition; 2003 Sep; 19(9):727-32. PubMed ID: 12921881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
    World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Level change of IL-10, IL-12 and TNF alpha in the serun of patients with hepatocellular carcinoma].
    He Y; Hu CH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):57-8. PubMed ID: 12536618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin in relation to hepatocellular carcinoma in patients with liver cirrhosis.
    Wang YY; Lin SY
    Horm Res; 2003; 60(4):185-90. PubMed ID: 14530607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum tumor necrosis factor-alpha and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis.
    Shiraki M; Terakura Y; Iwasa J; Shimizu M; Miwa Y; Murakami N; Nagaki M; Moriwaki H
    Nutrition; 2010 Mar; 26(3):269-75. PubMed ID: 19695831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
    Abbasi A; Bhutto AR; Butt N; Munir SM
    J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
    Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
    Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis.
    Verhelst X; Vanderschaeghe D; Castéra L; Raes T; Geerts A; Francoz C; Colman R; Durand F; Callewaert N; Van Vlierberghe H
    Clin Cancer Res; 2017 Jun; 23(11):2750-2758. PubMed ID: 27986746
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor necrosis factor alpha levels in patients with chronic liver diseases and its relationship to pathogenesis].
    Yuan AL; Luo YH; Liu SD
    Zhonghua Nei Ke Za Zhi; 1994 Oct; 33(10):672-4. PubMed ID: 7712914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
    Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
    Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum granulocyte colony stimulating factor in Turkish hepatocellular carcinoma patients.
    Kaya AO; Coskun U; Sancak B; Buyukberber S; Yildiz R; Gulbahar O; Benekli M; Ozenirler S
    Asian Pac J Cancer Prev; 2009; 10(3):403-6. PubMed ID: 19640182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
    Abdel-Razik A; Elhelaly R; Elzehery R; El-Diasty A; Abed S; Elhammady D; Tawfik A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):599-605. PubMed ID: 26741637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.